Jesper Grarup

2.5k total citations
16 papers, 357 citations indexed

About

Jesper Grarup is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jesper Grarup has authored 16 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Jesper Grarup's work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). Jesper Grarup is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). Jesper Grarup collaborates with scholars based in Denmark, United Kingdom and United States. Jesper Grarup's co-authors include Geneviève Chêne, Fleur Hudson, Abdel G. Babiker, Andrea Antinori, Anton Pozniak, François Raffi, Laura Richert, Clotilde Allavena, Remko van Leeuwen and José Ramón Arribas and has published in prestigious journals such as The Lancet, The Lancet Neurology and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Jesper Grarup

15 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesper Grarup Denmark 9 226 173 80 52 41 16 357
Marilyn McMurchie Australia 6 297 1.3× 241 1.4× 84 1.1× 94 1.8× 16 0.4× 11 447
WW Fawzi United States 10 122 0.5× 69 0.4× 84 1.1× 43 0.8× 61 1.5× 13 342
Faith Moyo South Africa 13 236 1.0× 100 0.6× 111 1.4× 43 0.8× 19 0.5× 24 325
Amanda Su United States 7 153 0.7× 44 0.3× 105 1.3× 46 0.9× 26 0.6× 11 296
Seyed Ahmad Seyed Alinaghi Iran 12 244 1.1× 45 0.3× 88 1.1× 18 0.3× 18 0.4× 35 426
Johnstone J. Kumwenda Malawi 11 408 1.8× 201 1.2× 167 2.1× 137 2.6× 24 0.6× 13 552
Stefan Kénel-Pierre United States 5 207 0.9× 113 0.7× 74 0.9× 58 1.1× 41 1.0× 15 319
Maria Letícia Rodrigues Ikeda Brazil 12 211 0.9× 82 0.5× 110 1.4× 212 4.1× 28 0.7× 27 408
Colette Smit Netherlands 14 325 1.4× 110 0.6× 309 3.9× 63 1.2× 31 0.8× 27 492
Benjamin Momo Kadia Cameroon 11 101 0.4× 33 0.2× 67 0.8× 33 0.6× 48 1.2× 43 328

Countries citing papers authored by Jesper Grarup

Since Specialization
Citations

This map shows the geographic impact of Jesper Grarup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper Grarup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper Grarup more than expected).

Fields of papers citing papers by Jesper Grarup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesper Grarup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper Grarup. The network helps show where Jesper Grarup may publish in the future.

Co-authorship network of co-authors of Jesper Grarup

This figure shows the co-authorship network connecting the top 25 collaborators of Jesper Grarup. A scholar is included among the top collaborators of Jesper Grarup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesper Grarup. Jesper Grarup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jensen, Jens‐Ulrik Stæhr, Lars Peters, Theis Skovsgaard Itenov, et al.. (2019). Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients. Clinical Chemistry and Laboratory Medicine (CCLM). 57(9). 1422–1431. 8 indexed citations
2.
Jepsen, Randi, John Brodersen, Erik Simonsen, et al.. (2018). Lolland-Falster Health Study: Study protocol for a household-based prospective cohort study. Scandinavian Journal of Public Health. 48(4). 382–390. 49 indexed citations
3.
Grarup, Jesper. (2016). Children and young people with perinatal HIV in Europe: epidemiological situation in 2014 and implications for the future. Eurosurveillance. 21(10). 30162–30162. 7 indexed citations
4.
Winston, Alan, Wolfgang Stöhr, Andrea Antinori, et al.. (2016). Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir–Ritonavir Plus Either Raltegravir or Tenofovir–Emtricitabine: A Substudy of the NEAT001/ANRS143 Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(2). 185–192. 8 indexed citations
5.
Jensen, Jens‐Ulrik Stæhr, Theis Skovsgaard Itenov, Katrín Þormar, et al.. (2016). Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial. Annals of Intensive Care. 6(1). 114–114. 13 indexed citations
6.
Grarup, Jesper, et al.. (2016). Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials. Clinical Trials. 13(2). 127–136. 11 indexed citations
7.
Sengeløv, Henrik, Caspar da Cunha‐Bang, Martin Iversen, et al.. (2015). Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections. EBioMedicine. 2(7). 699–705. 19 indexed citations
8.
Jensen, Jens‐Ulrik Stæhr, Maria Egede Johansen, Theis Skovsgaard Itenov, et al.. (2015). Non-recognized Liver Impairment in Infected Critically Ill Patients Is Frequent and Hazardous. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations
9.
Grarup, Jesper, C CAREY, Fleur Hudson, et al.. (2015). Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine. 16(S1). 14–23. 7 indexed citations
10.
Raffi, François, Abdel G. Babiker, Laura Richert, et al.. (2014). Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.. The Lancet Neurology. 384(9958). 1 indexed citations
11.
12.
Mocroft, Amanda, Peter Reiss, Aza Rakhmanova, et al.. (2014). A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe. Infection. 42(4). 757–762. 2 indexed citations
13.
Hullsiek, Katherine Huppler, Jonathan Kagan, Nicole Engen, et al.. (2014). Investigating the Efficacy of Clinical Trial Monitoring Strategies: Design and Implementation of the Cluster Randomized START Monitoring Substudy. Therapeutic Innovation & Regulatory Science. 49(2). 225–233. 10 indexed citations
14.
Castro, Hannah, Ali Judd, Diana M. Gibb, et al.. (2011). Risk of triple-class virological failure in children with HIV: a retrospective cohort study. The Lancet. 377(9777). 1580–1587. 85 indexed citations
15.
16.
Neaton, James D., Abdel G. Babiker, Janet Darbyshire, et al.. (2010). Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health. Clinical Trials. 7(6). 705–718. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilyn McMurchie Breakdown of academic impact, for papers by WW Fawzi Breakdown of academic impact, for papers by Faith Moyo Breakdown of academic impact, for papers by Amanda Su Breakdown of academic impact, for papers by Seyed Ahmad Seyed Alinaghi Breakdown of academic impact, for papers by Johnstone J. Kumwenda Breakdown of academic impact, for papers by Stefan Kénel-Pierre Breakdown of academic impact, for papers by Maria Letícia Rodrigues Ikeda Breakdown of academic impact, for papers by Colette Smit Breakdown of academic impact, for papers by Benjamin Momo Kadia
Rankless by CCL
2026